Inhibiting S6K2 gene offers potential treatment for drug-resistant melanoma

The lab of The Wistar Institute’s Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .